Advertisement

Thrombolytics and Invasive vs Conservative Strategies

  • Shilpesh S. Patel
  • H. Vernon Anderson
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

The coronary syndromes of unstable angina pectoris and non-Q-wave myocardial infarction (NQMI) represent a pathophysiologic continuum all the way from brief myocardial ischemia to partial, nontransmural myocardial necrosis. The clinical presentation of these two syndromes is identical, typically consisting of intermittent episodes of chest pain lasting from only a few minutes to hours, and occurring either at rest or with minimal exertion. Patients with unstable angina, by definitygn, sustain only myocardial ischemia, whereas patients with NQMI, by definition, sustain at least some myocardial necrosis as evidenced by the leakage of creatine phosphokinase-MB, troponin T, and troponin I, but without the development of Q-waves on the electrocardiogram. Thus, NQMI can be viewed as a manifestation of more prolonged or severe unstable angina. Clinically the two syndromes are similar with respect to cardiovascular mortality and morbidity. They may be thought of as warning signs of impending or threatening myocardial infarction (MI). Older natural history studies (1–3) have shown that the development of unstable angina is associated within a year with a 10%–20% incidence of death and a 20%–40% incidence of nonfatal MI. In addition, in more recent studies, 60% of patients hospitalized with unstable angina typically have required revascularization with either percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CAB G) within 1 yr.

Keywords

Unstable Angina Coronary Angioplasty Thrombolytic Agent Impaired Left Ventricular Function Recurrent Ischemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    DeFeyter PJ, Serruys PW. Percutaneous transluminal coronary angioplasty for unstable angina. In: Topol EJ, ed. Textbook of Interventional Cardiology, 2nd ed. WB Saunders, Philadelphia, 1994, pp. 274–291.Google Scholar
  2. 2.
    McClellan JR. Unstable angina: prognosis, noninvasive risk assessment, and strategies for management. Clin Cardiol 1994; 17: 229–238.CrossRefPubMedGoogle Scholar
  3. 3.
    Chester M, Chen L, Kaski JC. Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty. Br Heart J 1995; 73: 216–222.CrossRefPubMedGoogle Scholar
  4. 4.
    Sherman CT, Litvack F, Grunfest W, Lee M, Hickley A, Chaux A, et al. Coronary angioscopy in patients with unstable angina. N Engl J Med 1986; 315: 913–919.CrossRefPubMedGoogle Scholar
  5. 5.
    Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287–291.CrossRefPubMedGoogle Scholar
  6. 6.
    Capone G Wolfe NM, Meyer B, Meister SG. Frequency of intracoronary filling defects by angiography in angina pectoris at rest. Am J Cardiol 1985; 56: 403–406.CrossRefPubMedGoogle Scholar
  7. 7.
    Vatrovec GW, Cowley MJ, Overton H, Richardson DW. Intracoronary thrombus in syndromes of unstable myocardial ischemia. Am Heart J 1981; 102: 1202–1208.CrossRefGoogle Scholar
  8. 8.
    Freeman MR, Williams AE, Chisholm RJ, Armstrong PW. Intracoronary thrombus and complex morphology in unstable angina: relation to timing of angiography and in-hospital cardiac events. Circulation 1989; 80: 17–23.CrossRefPubMedGoogle Scholar
  9. 9.
    Arora RR, Platko WP, Bhadwar K, Simpfendorfer C. Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1989; 16: 226–229.CrossRefPubMedGoogle Scholar
  10. 10.
    Mabin TA, Holmes DR, Smith HC. Intracoronary thrombus: role in coronary occlusion complicating percutaneous tranluminal coronary angioplasty. J Am Coll Cardiol 1985; 5: 198–202.CrossRefPubMedGoogle Scholar
  11. 11.
    Sugrue DD, Holmes DR Jr, Smith HC. Coronary artery thrombus as a risk factor for acute vessel occlusion during coronary angioplasty: improving results. Br Heart J 1986; 56: 62–66.CrossRefPubMedGoogle Scholar
  12. 12.
    Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105–1111.CrossRefPubMedGoogle Scholar
  13. 13.
    Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med 1985; 313: 1369–1375.CrossRefPubMedGoogle Scholar
  14. 14.
    The TIMI IIIA investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest: results of the Thrombolysis in Myocardial Infarction (TIMI IIIA) trial. Circulation 1983; 87: 38–52.Google Scholar
  15. 15.
    The TIMI IIIB investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation 1994; 89: 1545–1556.CrossRefGoogle Scholar
  16. 16.
    Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, et al. One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trial. J Am Coll Cardiol 1995; 26: 1643–1650.CrossRefPubMedGoogle Scholar
  17. 17.
    Ellis SG, Roubin GS, King SB III, Douglas JS, Weintraub WS, Thomas RG, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 371–379.CrossRefGoogle Scholar
  18. 18.
    Sugrue DD, Holmes DR, Smith HC, Reeder GS, Lane GE, Vliestia RE, et al. Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results. Br Heart J 1986; 56: 62–67.CrossRefPubMedGoogle Scholar
  19. 19.
    Ambrose JA, Almeida OD, Sharma SK, Tore SR, Marmur JD, Israel DH, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA trial. Circulation 1994; 90: 69–77.CrossRefPubMedGoogle Scholar
  20. 20.
    Mehran R, Ambrose JA, Bongu RM, Almeida OD, Israel DH, Torre S, et al. Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial. J Am Coll Cardiol 1995; 26: 961–966.CrossRefPubMedGoogle Scholar
  21. 21.
    Jang IK, Gold HK, Ziskind AA, Fallon JT, Holt RE, Leinbach RC, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation 1989; 79: 920–928.CrossRefPubMedGoogle Scholar
  22. 22.
    Gold HK, Yasuda T, Jang IK, Guerrero JL, Falon JT, Leinbach RC, et al. Animal models for arterial thrombolysis and prevention of reocclusion-erythrocyte-rich versus platelet-rich thrombus. Circulation 1991;83(Supp1IV):IV26–1V40.Google Scholar
  23. 23.
    Zaret BL, Wackers FJ. Nuclear cardiology. N Engl J Med 1993;329: 775–783; 855–863.Google Scholar
  24. 24.
    Conti RC. Unstable angina: cost of conservative and invasive strategies using TIMI IIIB as a model. Clin Cardiol 1995; 8: 187–188.CrossRefGoogle Scholar
  25. 24a.
    Boden WE, O’Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative strategy. N Engl J Med 1998; 338: 1785–1792.CrossRefPubMedGoogle Scholar
  26. 24b.
    Tu JV, Sykora K, Naylor CD, for the Steering Committee of the Cardiac Care Network of Ontario. Assessing the outcomes of coronary artery bypass graft surgery: How many risk factors are enough. J Am Coll Cardiol 1997; 30: 1317–1323.CrossRefPubMedGoogle Scholar
  27. 25.
    Parisi AF, Khuri S. Deupree RH, Sharma GVRK, Scott SM, Luchi RJ. Medical compared with surgical management of unstable angina: 5-year mortality and morbidity in the Veterans Administration study. Circulation 1989; 80: 1176–1189.CrossRefPubMedGoogle Scholar
  28. 26.
    Sharma GVRK, Deupree RH, Rhuri SF, Parisi AF, Luchi RJ, Scott SM. Coronary bypass surgery improves survival in high-risk unstable angina: results of a Veterans Administration Cooperative Study with an 8-year follow-up. Circulation 1991;84(Suppl III):III260–III267.Google Scholar
  29. 27.
    Parisi AF, Folland ED, Haritgan P, et al. A comparison of angioplasty with medical therapy in the treatment of single vessel coronary artery disease. N Engl J Med 1992; 326: 10–26.CrossRefPubMedGoogle Scholar
  30. 28.
    Hueb WA, Bellotti G, Almeida de Oliveira S, et al. The Medicine, Angioplasty, or Surgery Study (MASS): a prospective randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol 1995; 26: 1600–1605.CrossRefPubMedGoogle Scholar
  31. 29.
    Cabri Trial Participants. First year results of CABRI (Coronary Angioplasty vs. Bypass Revascularization Investigation). Lancet 1995; 346: 1179–1184.CrossRefGoogle Scholar
  32. 30.
    RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993; 343: 573–580.Google Scholar
  33. 31.
    King SB, Lembo NJ, Kosinski AS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994; 331: 1044–1050.CrossRefPubMedGoogle Scholar
  34. 32.
    Hamm CW, Riemers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multi-vessel coronary disease. N Engl J Med 1994; 331: 1037–1043.CrossRefPubMedGoogle Scholar
  35. 33.
    Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multi-vessel disease (ERACI): in-hospital results and 1 year follow-up. J Am Coll Cardiol 1993; 22: 1060–1067.CrossRefPubMedGoogle Scholar
  36. 34.
    The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multi-vessel disease. N Engl J Med 1996; 335: 217–225.CrossRefGoogle Scholar
  37. 35.
    Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB, Hamm CW, et al. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995; 346: 1184–1189.CrossRefPubMedGoogle Scholar
  38. 36.
    Semen GG, Gensini GF, Poggesi L, Trotta F, Modesti PA, Boddi M, et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischemia in refractory unstable angina. Lancet 1990; 335: 615–618.CrossRefGoogle Scholar
  39. 37.
    Ardissino D, Barberis P, De Servi S, Mussini A, Rolla A, Visani L, et al. Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris. Am J Cardiol 1990; 66: 910–914.CrossRefPubMedGoogle Scholar
  40. 38.
    Chaudhary H, Crozier I, Hamer A, Foy S, Shirlaw, T, Kiram H. Tissue plasminogen activator using a rapid infusion low-dose regimen for unstable angina. Am J Cardiol 1992; 69: 173–175.CrossRefPubMedGoogle Scholar
  41. 39.
    Gold HK, Johns JA, Leinbach RC, Yasuda T, Grossbard E, Zusman R, et al. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation 1987; 75: 1192–1199.CrossRefPubMedGoogle Scholar
  42. 40.
    Romeo F, Rosano GMC, Martuscelli E, Comito M, Cardona N, Colistra C, et al. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina. J Am Coll Cardiol 1995; 25: 1295–1299.CrossRefPubMedGoogle Scholar
  43. 41.
    Topol EJ, Nicklas JM, Kander NH, Walton JA, Ellis SG, Gorman L, et al. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial. Am J Cardiol 1988; 62: 368–371.CrossRefPubMedGoogle Scholar
  44. 42.
    Williams DO, Topol EJ, Califf RM, Roberts R, Mancini J, Joelson JM, et al. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation 1990; 82: 376–383.CrossRefPubMedGoogle Scholar
  45. 43.
    Freeman MR, Langer A, Wilson RF, Morgan CD, Armstrong PW. Thrombolysis in unstable angina. Circulation 1992; 85: 150–157.CrossRefPubMedGoogle Scholar
  46. 44.
    van den Brand M, van Zijl A, Geuskens R, de Feyter J, Serruys PW, Simoons ML. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty. Eur Heart J 1991; 12: 1208–1214.CrossRefPubMedGoogle Scholar
  47. 45.
    Saran RK, Bhandari K, Narain VS, Ahuja RC, Puri VK, Thakur R, et al. Intarvenous streptokinase in the management of a subset of patients with unstable angina: a randomized controlled trial. Int J Cardiol 1990; 28: 209–213.CrossRefPubMedGoogle Scholar
  48. 46.
    Chatterjee SS, Bhattacharya R, Das Biswas A, Ghosh S, Ghosh SP, Biswas PK, et al. Intravenous thrombolytic therapy in unstable angina. Indian Heart J 1993; 45: 103–108.PubMedGoogle Scholar
  49. 47.
    White HD, French JK, Norris RM, Williams BF, Hart HH, Cross BC. Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression. Br Heart J 1995; 73: 500–505.CrossRefPubMedGoogle Scholar
  50. 48.
    Schreiber TL, Macina G, McNulty A, Bunnell P, Kikel M, Miller DH, et al. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction. Am J Cardiol 1989; 64: 840–844.CrossRefPubMedGoogle Scholar
  51. 49.
    Sansa M, Cernigliaro C, Campi A, Simonetti I. Effects of urokinase and heparin on minimal cross-sectional area of the culprit narrowing in unstable nagina pectoris. Am J Cardiol 1991; 68: 451–456.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Shilpesh S. Patel
  • H. Vernon Anderson

There are no affiliations available

Personalised recommendations